GLP-1 receptor agonists and the risk of atrial fibrillation: a real-world evidence

被引：0
|
作者：
Shin, J. I. [1 ]
Xu, Y. [1 ]
Boyle, T. [2 ]
Lyu, B. [1 ]
Ballew, S. [1 ]
Selvin, E. [1 ]
Chang, A. [3 ]
Inker, L. [4 ]
Grams, M. [5 ]
机构：
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Epidemiol, Baltimore, MD USA
[2] Univ Penn, Internal Med, Philadelphia, PA USA
[3] Geisinger Commonwealth Sch Med, Internal Med, Scranton, PA USA
[4] Tufts Med Ctr, Internal Med, Boston, MA USA
[5] New York Univ, Grossman Sch Med, Internal Med, New York, NY USA
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2023年 / 197卷
关键词：
D O I：
10.1016/j.diabres.2023.110309
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
IDF2022-04
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation
    Zhong, Jiani
    Chen, Hang
    Liu, Qiming
    Zhou, Shenghua
    Liu, Zhenguo
    Xiao, Yichao
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2024, 14 (05)
  • [2] GLP-1 RECEPTOR AGONISTS AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION AND DIABETES
    Rangavajla, Gautam
    Ayub, Muhammad Talha
    Thoma, Floyd
    Mulukutla, Suresh
    Zhu, Jianhui
    Jain, Sandeep K.
    Saba, Samir F.
    Bhonsale, Aditya
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 192 - 192
  • [3] ORIGINAL RESEARCH Difference in Gastrointestinal Risk Associated with Use of GLP-1 Receptor Agonists: A Real-World Pharmacovigilance Study
    Zhou, Yu
    Chen, Mingyu
    Liu, Libin
    Chen, Zhou
    DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 155 - 163
  • [4] Comparative cardiovascular effects of GLP-1 agonists using real-world data
    Wallia, Amisha
    O'Brien, Matthew
    Hakimian, Stephanie
    Kang, Raymond
    Cooper, Andrew
    Lancki, Nicola
    Stephen, John J.
    Aikman, Cassandra
    Liss, David
    Parker, Emily
    Ackermann, Ronald T.
    ENDOCRINOLOGY DIABETES & METABOLISM, 2023, 6 (03)
  • [5] Real-world sex differences in type 2 diabetes patients treated with GLP-1 receptor agonists
    Piccini, Sara
    Favacchio, Giuseppe
    Morenghi, Emanuela
    Mazziotti, Gherardo
    Lania, Andrea G. A.
    Mirani, Marco
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 212
  • [6] Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study
    Sara Piccini
    Giuseppe Favacchio
    Cristina Panico
    Emanuela Morenghi
    Franco Folli
    Gherardo Mazziotti
    Andrea Gerardo Lania
    Marco Mirani
    Cardiovascular Diabetology, 22
  • [7] Beyond Glycemic Control: GLP-1 Receptor Agonists and Their Impact on Calcium Homeostasis in Real-World Patients
    Alenezi, Bandar T.
    Elfezzani, Nadra
    Uddin, Rukhsana
    Patel, Hinali
    Chester, Sydney
    Abdelmaksoud, Ahmed
    Hussein, Mohammad H.
    Zaitone, Sawsan A.
    Fawzy, Manal S.
    Aiash, Hani
    Toraih, Eman A.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (16)
  • [8] Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study
    Piccini, Sara
    Favacchio, Giuseppe
    Panico, Cristina
    Morenghi, Emanuela
    Folli, Franco
    Mazziotti, Gherardo
    Lania, Andrea Gerardo
    Mirani, Marco
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [9] GLP-1 and dual GIP/GLP-1 receptor agonists increase risk of aspiration
    Reactions Weekly, 2025, 2044 (1) : 3 - 3
  • [10] GLP-1 receptor agonists and the risk of colorectal cancer
    Kakkar, Ashish Kumar
    MEDICAL HYPOTHESES, 2014, 82 (06) : 796 - 796
12345